Your browser doesn't support javascript.
loading
Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma.
Yamagishi, Ryota; Kamachi, Fumitaka; Nakamura, Masaru; Yamazaki, Shota; Kamiya, Tomonori; Takasugi, Masaki; Cheng, Yi; Nonaka, Yoshiki; Yukawa-Muto, Yoshimi; Thuy, Le Thi Thanh; Harada, Yohsuke; Arai, Tatsuya; Loo, Tze Mun; Yoshimoto, Shin; Ando, Tatsuya; Nakajima, Masahiro; Taguchi, Hayao; Ishikawa, Takamasa; Akiba, Hisaya; Miyake, Sachiko; Kubo, Masato; Iwakura, Yoichiro; Fukuda, Shinji; Chen, Wei-Yu; Kawada, Norifumi; Rudensky, Alexander; Nakae, Susumu; Hara, Eiji; Ohtani, Naoko.
Afiliación
  • Yamagishi R; Department of Pathophysiology, Osaka Metropolitan University, Graduate School of Medicine, Osaka, Japan (formerly, Osaka City University).
  • Kamachi F; Department of Pathophysiology, Osaka Metropolitan University, Graduate School of Medicine, Osaka, Japan (formerly, Osaka City University).
  • Nakamura M; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Noda, Chiba, Japan.
  • Yamazaki S; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Noda, Chiba, Japan.
  • Kamiya T; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Noda, Chiba, Japan.
  • Takasugi M; Department of Pathophysiology, Osaka Metropolitan University, Graduate School of Medicine, Osaka, Japan (formerly, Osaka City University).
  • Cheng Y; Department of Pathophysiology, Osaka Metropolitan University, Graduate School of Medicine, Osaka, Japan (formerly, Osaka City University).
  • Nonaka Y; Department of Pathophysiology, Osaka Metropolitan University, Graduate School of Medicine, Osaka, Japan (formerly, Osaka City University).
  • Yukawa-Muto Y; Department of Pathophysiology, Osaka City University, Graduate School of Medicine, Osaka, Japan.
  • Thuy LTT; Department of Pathophysiology, Osaka Metropolitan University, Graduate School of Medicine, Osaka, Japan (formerly, Osaka City University).
  • Harada Y; Department of Hepatology, Osaka Metropolitan University, Graduate School of Medicine, Osaka, Japan (formerly, Osaka City University).
  • Arai T; Department of Hepatology, Osaka Metropolitan University, Graduate School of Medicine, Osaka, Japan (formerly, Osaka City University).
  • Loo TM; Laboratory of Pharmaceutical Immunology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
  • Yoshimoto S; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Noda, Chiba, Japan.
  • Ando T; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Noda, Chiba, Japan.
  • Nakajima M; Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
  • Taguchi H; Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.
  • Ishikawa T; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Noda, Chiba, Japan.
  • Akiba H; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Noda, Chiba, Japan.
  • Miyake S; Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Noda, Chiba, Japan.
  • Kubo M; Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.
  • Iwakura Y; Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan.
  • Fukuda S; Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan.
  • Chen WY; Division of Molecular Pathology, Research Institute for Biomedical Science, Tokyo University of Science, Noda, Chiba, Japan.
  • Kawada N; Laboratory for Cytokine Regulation, Research Center for Integrative Medical Science (IMS), RIKEN Yokohama Institute, Yokohama, Kanagawa, Japan.
  • Rudensky A; Center for Animal Disease Models, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan.
  • Nakae S; Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.
  • Hara E; Gut Environmental Design Group, Kanagawa Institute of Industrial Science and Technology, Kawasaki, Kanagawa, Japan.
  • Ohtani N; Transborder Medical Research Center, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Sci Immunol ; 7(72): eabl7209, 2022 06 24.
Article en En | MEDLINE | ID: mdl-35749514
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma Hepatocelular / Proteínas de Unión a Fosfato / Proteínas Citotóxicas Formadoras de Poros / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Sci Immunol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma Hepatocelular / Proteínas de Unión a Fosfato / Proteínas Citotóxicas Formadoras de Poros / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Sci Immunol Año: 2022 Tipo del documento: Article